Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.

Biotechnology

Nurix

Arthur T. Sands

Praveen Srivastava

Nathalie M.e. Martineau

Paula G. O’Connor

Elizabeth Bosch

George W. Cole

Eren Demirhan

Hans van Houte

Raf Lambrecht

Christine Ring

Eric Schlezinger

Buckley Kohlhauff

Janine Powers

Seema P. Rogers

Christopher B. Phelps

Gwenn M. Hansen

The executive team at Nurix has a history of working in the healthcare industry and holds degrees in management science and biology from Stanford University as well as psychology from Naropa University. The team has experience with strategy, portfolio management, and business development. Additionally, the team has experience in founding and operating Fast Track Systems.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Nurix

Leadership Team

Board of Directors